Novi Zeland - engleski - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - emicizumab 150 mg/ml - solution for injection - 150 mg/ml - active: emicizumab 150 mg/ml excipient: arginine aspartic acid histidine poloxamer 188 water for injection - hemlibra is indicated for routine prophylaxis to prevent bleeding or reduce the frequency of bleeding episodes in adult and paediatric patients with haemophilia a (congenital factor viii deficiency) with or without factor viii inhibitors.

Novi Zeland - engleski - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - emicizumab 150 mg/ml - solution for injection - 150 mg/ml - active: emicizumab 150 mg/ml excipient: arginine aspartic acid histidine poloxamer 188 water for injection - hemlibra is indicated for routine prophylaxis to prevent bleeding or reduce the frequency of bleeding episodes in adult and paediatric patients with haemophilia a (congenital factor viii deficiency) with or without factor viii inhibitors.

Novi Zeland - engleski - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - emicizumab 30 mg/ml - solution for injection - 30 mg/ml - active: emicizumab 30 mg/ml excipient: arginine aspartic acid histidine poloxamer 188 water for injection - hemlibra is indicated for routine prophylaxis to prevent bleeding or reduce the frequency of bleeding episodes in adult and paediatric patients with haemophilia a (congenital factor viii deficiency) with or without factor viii inhibitors.

Izrael - engleski - Ministry of Health

roche pharmaceuticals (israel) ltd - emicizumab - solution for injection - emicizumab 150 mg / 1 ml - emicizumab - hemlibra is indicated for routine prophylaxis to prevent bleeding or reduce the frequency of bleeding episodes in patients with hemophilia a (congenital factor viii deficiency) with or without factor viii inhibitors.

Izrael - engleski - Ministry of Health

roche pharmaceuticals (israel) ltd - emicizumab - solution for injection - emicizumab 30 mg / 1 ml - emicizumab - hemlibra is indicated for routine prophylaxis to prevent bleeding or reduce the frequency of bleeding episodes in patients with hemophilia a (congenital factor viii deficiency) with or without factor viii inhibitors.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

radiometer pacific pty ltd - 65331 - calibration gas/non-refillable cylinder - calibration gas for the transcutaneous monitor/patient monitoring systems.

Bangladeš - engleski - DGDA (Directorate General of Drug Administration)

libra infusion limited - metronidazole - iv infusion - 500 mg/100 ml

Australija - engleski - Department of Health (Therapeutic Goods Administration)

air liquide healthcare pty ltd - 65331 - calibration gas/non-refillable cylinder - gas used for the periodic calibration of gas sensors on nitric oxide administration and monitoring devices.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

air liquide healthcare pty ltd - 65331 - calibration gas/non-refillable cylinder - gas used for the periodic calibration of gas sensors on nitric oxide administration and monitoring devices.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

sentec monitoring pty ltd - 65331 - calibration gas/non-refillable cylinder - the service gas, model gas-0812, serves as calibration gas for the sentec?s sensors that monitor tcpco2 and/or tcpo2 (v-sign? sensor 2 and oxivent? sensor). the service gas, model gas-0812, is intended for use only with the docking station integrated in sentec?s digital monitor.